Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD modeling of routinely used off-label drugs in premature neonates
NL-OMON44214Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of doxapram, fentanyl, midazolam, acetaminophen, phenobarbital and 4 more in pain, seizure disorder, infant apnea and 4 more, sponsored by Erasmus MC. Primary endpoints: Clearance and Volume of distribution. Started Sep 2014; status: active, not recruiting.
02
Drugs
doxapramfentanylmidazolamacetaminophenphenobarbital
03
Conditions
painseizure disorderinfant apneapersistent pulmonary hypertension of the newborn (PPHN)patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NL-OMON44214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44214.